We are live on ! Find out more
BCM

BluePath Capital Management Portfolio holdings

AUM $182M
1-Year Est. Return 38.9%
This Fund
S&P 500
This Quarter Est. Return
-4.59%
1 Year Est. Return
+38.9%
3 Year Est. Return
+101.38%
5 Year Est. Return
10 Year Est. Return
AUM
$96.1M
AUM Growth
-$90M
Cap. Flow
-$81.6M
Cap. Flow %
-84.93%
Top 10 Hldgs %
48.82%
Holding
111
New
10
Increased
2
Reduced
69
Closed
28

Sector Composition

Rank Sector Weight
1 Miscellaneous 39.16%
2 Technology 17.47%
3 Financials 10.39%
4 Consumer Discretionary 7.17%
5 Consumer Staples 5.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYB icon
101
LyondellBasell Industries
LYB
$20.6B
-8,814
Closed -$662K
MU icon
102
Micron Technology
MU
$1.1T
-10,710
Closed -$1.02M
NAK
103
Northern Dynasty Minerals
NAK
$793M
-20,300
Closed -$13.5K
SJNK icon
104
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.73B
-33,018
Closed -$833K
SLB icon
105
SLB Ltd
SLB
$83.2B
-23,197
Closed -$924K
SPGI icon
106
S&P Global
SPGI
$121B
-806
Closed -$389K
SRLN icon
107
State Street Blackstone Senior Loan ETF
SRLN
$5.55B
-20,697
Closed -$867K
UNH icon
108
UnitedHealth
UNH
$340B
-541
Closed -$293K
UPS icon
109
United Parcel Service
UPS
$85.3B
-2,721
Closed -$340K
VRT icon
110
Vertiv
VRT
$99B
-2,272
Closed -$282K
VZ icon
111
Verizon
VZ
$210B
-25,461
Closed -$971K

Similar funds

BluePath Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, BluePath Capital Management held 111 positions worth $96.1M, down 48% from $186M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

BluePath Capital Management withdrew a net $81.6M in Q1 2025, closing 28 positions and reducing 69 holdings. Its most notable exit was Eli Lilly, an estimated $1.26M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, down from 41% a quarter earlier, followed by Technology and Financials.

Against the trend, BluePath Capital Management opened a new position in Strategy Inc worth $908K.

  • BluePath Capital Management's largest Q1 2025 buy was Strategy Inc: 3,150 shares worth $908K.
  • BluePath Capital Management added most to Applovin in Q1 2025, an estimated $692K increase.
  • BluePath Capital Management's biggest Q1 2025 reduction was Nicholas Fixed Income Alternative ETF, cutting an estimated $18.2M.
  • BluePath Capital Management fully exited Eli Lilly in Q1 2025, selling an estimated $1.26M.
  • BluePath Capital Management's ten largest holdings make up 49% of its $96.1M portfolio in Q1 2025.
  • BluePath Capital Management opened 10 new positions and closed 28 in Q1 2025.
  • BluePath Capital Management's portfolio value fell 48% quarter-over-quarter to $96.1M.

Based on BluePath Capital Management's 13F filing for Q1 2025, filed 6 May 2025.